Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oracure is a brand name used for several distinct over-the-counter (OTC) oral healthcare products available in multiple countries, primarily indicated for the treatment of mouth ulcers, oral sores, and related conditions. The most common formulation, such as Oracure Dental Gel marketed by companies like Octavius Pharma, is a combination product containing **choline salicylate** (a non-steroidal anti-inflammatory drug that inhibits prostaglandin synthesis) and **lidocaine** (a local anesthetic that blocks nerve pain signals). Another version is a vitamin supplement tablet containing folic acid, riboflavin, niacinamide, and lactic acid bacillus spores, used to manage mouth ulcers caused by nutritional deficiencies. In Japan, an OTC version contains **tranexamic acid** as an anti-inflammatory agent for throat and oral inflammation. Additionally, a homeopathic product under the same name contains calcarea phosphoricum for teething-related relief in infants. These products are generally small-molecule or supplement-based formulations rather than novel research-stage biologics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oracure.